What Is Driving the Global Fedratinib Market Toward USD 285.4 Million by 2032 at a 8.7% CAGR?
Global Fedratinib market size was valued at USD 142.5 million in 2024. The market is projected to grow from USD 158.7 million in 2025 to USD 285.4 million by 2032, exhibiting a CAGR of 8.7% during the forecast period. Fedratinib is a Janus kinase 2 (JAK2) inhibitor used primarily for treating myelofibrosis, a rare bone marrow disorder. This targeted therapy works by blocking abnormal signaling...
0 Комментарии 0 Поделились 92 Просмотры 0 предпросмотр